SIMCERE PHARMACEUTICAL GROUP (SCR)

Overview Price 10.23 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $10.23 Daily Range $0.00 - $0.00 52-Week Range $7.12 - $13.72 Volume 0 SIMCERE PHARMACEUTICAL GROUP is a leading manufacturer and supplier of branded generic pharmaceuticals in the rapidly growing China market. Their strategic focus is to introduce first to market generic and innovative pharmaceuticals for the treatment of diseases with high incidence and or mortality rate and for which there is a clear demand for more effective pharmacotherapy. Other Resources for SCR Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Bristol-Myers, Simcere Extend Ties December 14, 2011 Zacks Blog: Simcere Pharma Misses on All Fronts November 15, 2011 Zacks Blog: Simcere Drug Cleared in China August 29, 2011 Zacks Blog: Simcere Pharma Beats on Bottom Line August 16, 2011 Zacks Blog: Revenues Rise at Simcere Pharma May 12, 2011 SIMCERE PHARMACEUTICAL GROUP is a leading manufacturer and supplier of branded generic pharmaceuticals in the rapidly growing China market. Their strategic focus is to introduce first to market generic and innovative pharmaceuticals for the treatment of diseases with high incidence and or mortality rate and for which there is a clear demand for more effective pharmacotherapy.   Brokerage Analyst Recommendations 5 Brokerage Firms Covering SCR   Strong Buy 0 Buy 0 Hold 5 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 3   SCR Ratings: BUY  SELL  HOLD SCR Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 3 Buy 0 Sell   Top Buy Analysis BUY: SCR Company: SIMCERE PHARMA ADS Points: 10.26 Start Price: $6.42 Start Date: 05/20/2009 8:20 AM supratrade1 P&P Score: 99.71 Recs: -1.54% per month Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	12/14/11	Bristol-Myers, Simcere Extend Ties - Analyst Blog	0
Zacks_Analysts	0.00	11/15/11	Simcere Pharma Misses on All Fronts - Analyst Blog	0
Zacks_Analysts	0.00	08/29/11	Simcere Drug Cleared in China - Analyst Blog	0
Zacks_Analysts	0.00	08/22/11	Silicom's Promising Growth Drivers - Analyst Blog	0
Zacks_Analysts	0.00	08/16/11	Simcere Pharma Beats on Bottom Line - Analyst Blog	0
Zacks_Analysts	0.00	07/12/11	Airgas Partners to Supply AiRx DEF - Analyst Blog	0
Zacks_Analysts	0.00	05/12/11	Revenues Rise at Simcere Pharma - Analyst Blog	0
Zacks_Analysts	0.00	03/30/11	AGCO Fendt Tractor a Record Setter - Analyst Blog	0
Zacks_Analysts	0.00	03/09/11	Revs Rise at Simcere Pharma - Analyst Blog	0
Zacks_Analysts	0.00	02/01/11	Pelangio announces major gold drilling programs in Ghana for 2011 - Analyst Blog	0

Pages: [ 1 ]  2   3  >>

Commentary

BUY: SIMCERE PHARMA ADS (SCR) Start Price: $6.42 Points: +10.26 Created: 05/20/2009 -1.54% per month Comments: 0 | Comment supratrade1 Recs:

BUY: SIMCERE PHARMA ADS (SCR) Start Price: $15.87 Points: -27.36 Created: 01/01/2008 Comments: 0 | Comment WENCEO Recs:

BUY: SIMCERE PHARMA ADS (SCR) Start Price: $13.55 Points: -16.30 Created: 01/01/2008 Comments: 0 | Comment 16086hacienda Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
supratrade1	99.71	BUY	One to Three Months	05/20/2009	$6.42	$10.25 (0.00%)	+59.66%	+49.40%	+10.26	view close
WENCEO	41.27	BUY	Six Months to a Year	01/01/2008	$15.87	$10.25 (0.00%)	-35.41%	-8.05%	-27.36
16086hacienda	9.40	BUY	Six Months to a Year	01/01/2008	$13.55	$10.25 (0.00%)	-24.35%	-8.05%	-16.30